• No results found

18 results with keyword: 'anemia and survival in childhood acute lymphoblastic leukemia'

Anemia and survival in childhood acute lymphoblastic leukemia.

Several studies have demonstrated that patients with childhood acute lymphoblastic leukemia presenting with mild anemia at diagnosis have an increased risk of poor outcome compared

Protected

N/A

7
0
0
2021
Steroid response as prognostic factor and its correlation with molecular assessment of childhood acute lymphoblastic leukemia

Steroid response as prognostic factor and its correlation with molecular assessment of childhood acute lymphoblastic leukemia.. Keywords: acute lymphoblastic leukemia,

Protected

N/A

6
0
0
2020
Childhood leukemia: central nervous system abnormalities during and after treatment

The patients had various types of childhood leukemia, including 14 cases of acute lymphoblastic leukemia, 3 cases of acute myelogenous leukemia, 1 case of acute promyelogenous

Protected

N/A

16
0
0
2020
Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit

AA, aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myelogenous leukemia; GVHD, graft-versus-host disease; HPS, Hemophagocytic

Protected

N/A

5
0
0
2020
WILMS' TUMOR GENE 1 (WT1) EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

Conclusion: This study suggest that Wt1 expression in childhood acute lymphoblastic leukemia is very variable and much more expressed in t cell leukemia than

Protected

N/A

5
0
0
2020
Multiple complications of the induction phase chemotherapy for childhood acute lymphoblastic leukemia

Multiple complications of the induction phase chemotherapy for childhood acute lymphoblastic leukemia.. Journal

Protected

N/A

6
0
0
2020
Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia

Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. Treating childhood

Protected

N/A

6
0
0
2021
A causal mechanism for childhood acute lymphoblastic leukaemia.

Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Case-control study

Protected

N/A

44
0
0
2020
High Dose Methotrexate in Treatment of Acute Lymphoblastic Leukemia: Toxicity Profile and Comparison of Tolerability
Between Two Dosage Schedules.

elimination delay of methotrexate in high-dose therapy of childhood. acute lymphoblastic leukemia in China Pediatr

Protected

N/A

71
0
0
2019
MicroRNA-binding site polymorphisms in hematological malignancies

ALL: Acute lymphoblastic leukemia; AML: Acute myeloid leukemia; CDS: Coding sequence; CML: Chronic myeloid leukemia; ceRNA: Competing endogenous RNA; DFS: Disease-free survival;

Protected

N/A

6
0
0
2020
An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells

HL60 (acute promyelocytic leukemia), MOLT-4 (acute lymphoblastic leukemia) and CCRF-CEM (acute lymphoblastic leukemia), BEAS (normal human bronchial epithelium) and HUVEC

Protected

N/A

14
0
0
2020
2 Flow-Cytometry Based Studies

Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia, Leukemia, 13

Protected

N/A

16
0
0
2021
Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China

ALL: Acute lymphoblastic leukemia; T-ALL: T-cell acute lymphoblastic leukemia; B-ALL: B-cell acute lymphoblastic leukemia; MRD: Minimal residual disease; PR: Prednisone response;

Protected

N/A

11
0
0
2020
The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia

Keywords: ABCA2 transporter, ABCA3 transporter, multidrug resistance, childhood acute lymphoblastic leukemia, molecular docking, tertiary

Protected

N/A

8
0
0
2020
Chromosomal Aberrations in ETV6/RUNX1-positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization

: Chromosomal Aberrations in ETV6/ RUNX1 -positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization. Molecular Cytogenetics

Protected

N/A

6
0
0
2020
Prevalence and Clinical Implication of Partial Tandem Duplication of the Mixed Lineage Leukemia Gene in Pediatric Acute Leukemia

Probability of Survival in Acute Lymphoblastic Leukemia (ALL) Patients according to Mixed Lineage Leukemia Gene – Partial Tandem Duplication (MLL-PTD) and Lactate Dehydrogenase

Protected

N/A

9
0
0
2021
Treatment related deaths in childhood acute lymphoblastic leukemia

differences in response to infection and inflammation have been described in some investigations using animal models as well as human studies 89,90 but has never been

Protected

N/A

154
0
0
2021
Immunotherapy in childhood B-cell acute lymphoblastic leukemia

Immunotherapy, specifically bispecific T-cell engaging antibody therapy and chimeric antigen receptor T-cell therapy, has proven an effective treatment for relapsed and refractory

Protected

N/A

22
0
0
2021

Upload more documents and download any material studies right away!